Overview

A Study to Evaluate the Safety and Tolerability and Explore the Efficacy of Zonisamide as add-on Therapy in Elderly Patients With Refractory Partial Seizures

Status:
Terminated

Trial end date:
2011-08-01

Target enrollment:

Participant gender:

Summary

A two arm, randomized, double-blind study comparing zonisamide with placebo. The zonisamide arm will consist of 100 subjects and the placebo arm of 50 subjects. Study medication will be administered as an add-on treatment to the subject's current 1 or 2 anti-epileptic (AEDs).

Phase:

Phase 4

Details

Lead Sponsor:

Eisai Limited

Treatments:

Zonisamide